241 related articles for article (PubMed ID: 16697151)
1. A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients.
San L; Arranz B; Querejeta I; Barrio S; De la Gándara J; Pérez V
Eur Psychiatry; 2006 Dec; 21(8):539-43. PubMed ID: 16697151
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation.
Castle DJ; Udristoiu T; Kim CY; Sarosi A; Pidrman V; Omar AN; Rosales JI; Melamed Y; Isik T; Karagianis J; Treuer T
World J Biol Psychiatry; 2009; 10(1):43-53. PubMed ID: 19137460
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation.
Katagiri H; Fujikoshi S; Suzuki T; Fujita K; Sugiyama N; Takahashi M; Gomez JC
BMC Psychiatry; 2013 Jan; 13():20. PubMed ID: 23311957
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
Huang CL; Hwang TJ; Chen YH; Huang GH; Hsieh MH; Chen HH; Hwu HG
J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540
[TBL] [Abstract][Full Text] [Related]
5. Intramuscular olanzapine versus intramuscular aripiprazole for the treatment of agitation in patients with schizophrenia: A pragmatic double-blind randomized trial.
Kittipeerachon M; Chaichan W
Schizophr Res; 2016 Oct; 176(2-3):231-238. PubMed ID: 27461399
[TBL] [Abstract][Full Text] [Related]
6. An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder.
Centorrino F; Meyers AL; Ahl J; Cincotta SL; Zun L; Gulliver AH; Kinon BJ; Houston JP
Hum Psychopharmacol; 2007 Oct; 22(7):455-62. PubMed ID: 17708578
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.
Breier A; Meehan K; Birkett M; David S; Ferchland I; Sutton V; Taylor CC; Palmer R; Dossenbach M; Kiesler G; Brook S; Wright P
Arch Gen Psychiatry; 2002 May; 59(5):441-8. PubMed ID: 11982448
[TBL] [Abstract][Full Text] [Related]
8. A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia.
Suzuki H; Gen K; Takahashi Y
Hum Psychopharmacol; 2014 Jan; 29(1):83-8. PubMed ID: 24424709
[TBL] [Abstract][Full Text] [Related]
9. A prospective, observational study of the safety and effectiveness of intramuscular psychotropic treatment in acutely agitated patients with schizophrenia and bipolar mania.
Perrin E; Anand E; Dyachkova Y; Wagner T; Frediani S; Ballerini A;
Eur Psychiatry; 2012 May; 27(4):234-9. PubMed ID: 20620029
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorder.
Lambert M; Huber CG; Naber D; Schacht A; Wagner TT; Hundemer HP; Karow A; Schimmelmann BG
Pharmacopsychiatry; 2008 Sep; 41(5):182-9. PubMed ID: 18763220
[TBL] [Abstract][Full Text] [Related]
11. [New formulations of olanzapine in the treatment of acute agitation].
Bartkó G
Neuropsychopharmacol Hung; 2006 Dec; 8(4):171-8. PubMed ID: 17211052
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania.
Meehan K; Zhang F; David S; Tohen M; Janicak P; Small J; Koch M; Rizk R; Walker D; Tran P; Breier A
J Clin Psychopharmacol; 2001 Aug; 21(4):389-97. PubMed ID: 11476123
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
San L; Estrada G; Oudovenko N; Vieta E
BMC Psychiatry; 2017 Apr; 17(1):126. PubMed ID: 28376877
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, randomized comparison study of efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in patients with schizophrenia and acute agitated behavior.
Chan HY; Ree SC; Su LW; Chen JJ; Chou SY; Chen CK; Chen YS
J Clin Psychopharmacol; 2014 Jun; 34(3):355-8. PubMed ID: 24743717
[TBL] [Abstract][Full Text] [Related]
15. Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation.
Marder SR; Sorsaburu S; Dunayevich E; Karagianis JL; Dawe IC; Falk DM; Dellva MA; Carlson JL; Cavazzoni PA; Baker RW
J Clin Psychiatry; 2010 Apr; 71(4):433-41. PubMed ID: 20156413
[TBL] [Abstract][Full Text] [Related]
16. Intramuscular aripiprazole in the acute management of psychomotor agitation.
De Filippis S; Cuomo I; Lionetto L; Janiri D; Simmaco M; Caloro M; De Persis S; Piazzi G; Simonetti A; Telesforo CL; Sciarretta A; Caccia F; Gentile G; Kotzalidis GD; Girardi P
Pharmacotherapy; 2013 Jun; 33(6):603-14. PubMed ID: 23505124
[TBL] [Abstract][Full Text] [Related]
17. Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients.
Lindborg SR; Beasley CM; Alaka K; Taylor CC
Psychiatry Res; 2003 Jul; 119(1-2):113-23. PubMed ID: 12860365
[TBL] [Abstract][Full Text] [Related]
18. Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine.
Walther S; Moggi F; Horn H; Moskvitin K; Abderhalden C; Maier N; Strik W; Müller TJ
J Clin Psychopharmacol; 2014 Feb; 34(1):124-8. PubMed ID: 24346752
[TBL] [Abstract][Full Text] [Related]
19. Intramuscular olanzapine in patients with schizophrenia: an observational study in an emergency room.
Damsa C; Adam E; Lazignac C; De Gregorio F; Mihai A; Lejeune J; Sarasin F; Allen MH
Bull Soc Sci Med Grand Duche Luxemb; 2008; (2):209-16. PubMed ID: 18561597
[TBL] [Abstract][Full Text] [Related]
20. A post hoc analysis of transitioning to oral treatment with olanzapine or haloperidol after 24-hour intramuscular treatment in acutely agitated adult patients with schizophrenia.
Battaglia J; Houston JP; Ahl J; Meyers AL; Kaiser CJ
Clin Ther; 2005 Oct; 27(10):1612-8. PubMed ID: 16330297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
